ConductScience.org, home

Trial · NCT07887009

Attitudes, Experience and Adaptation to Family Presence in the ICU

NCT07887009, Not applicable, Enrolling by invitation, Universitair Ziekenhuis Brussel

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Attitudes, Experience and Adaptation to Family Presence in the ICU. Trials, record NCT07887009. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887009

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Attitudes, Experience and Adaptation to Family Presence in the ICU
NCT number
NCT07887009
Status
Enrolling by invitation
Phases
Not applicable
Enrollment
80 participants, estimated
Lead sponsor
Universitair Ziekenhuis Brussel
Conditions
ICU Staff Attitudes Toward Family Presence, ICU Staff Experience of Family Presence, Adaptation to Extended Family Presence in the ICU, Association Between Stress Sensitivity and Attitudes Toward Family Presence
Interventions
questionnaire
First posted
2026-10-21
Last updated
2026-10-21

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChanges from baseline in healthcare providers'attitudes and perceptions regarding family presence in the adult ICU (Intensive Care Unit)Baseline (T0) assessed once before implementation of the extended visiting policy. Follow- up (T2) assessed once approximately 6 months after implementation of the extended visiting policy.
The change in healthcare providers' attitudes and perceptions is measured using the BAVIQ score prior to the introduction of the more flexible visitation policy (baseline) and six months after implementation (Follow-up) . The primary out is the change in the BAVIQ score between the baseline measurements and Follow-up. No predifined threshold is used; scores are analysed as continuous measures. Time points: T0 = baseline time point, before implementation of the extended visiting policy. T1 = implementation time point, during the early implementation period of the extended visiting policy. T2 = follow-up time point, approximately 6 months after implementation of the extended visiting policy.
Primaryassociation between individual vulnerability to stress and overload and attitudes and perceptions regarding family presence.Baseline (T0) assessed once before implementation of the extended visiting policy.
The susceptibility to individual vulnerability to stress and overload is measured using the IPIP-NEO facet scales for Anxiety and Vulnerability at baseline. The outcome measures are the IPIP-NEO Anxiety and Vulnerability facet scores, their association with the BAVIQ score at baseline, and their association with the change in the BAVIQ score between baseline and follow up. Time points: T0 = baseline time point, before implementation of the extended visiting policy. T1 = implementation time point, during the early implementation period of the extended visiting policy. T2 = follow-up time point, approximately 6 months after implementation of the extended visiting policy.
Secondaryfactors that may influence the ICU staff 's experience of family presence during careT1: implementation period: assessed during a 2-week data collection period during the early implementation period of the extended visiting policy
This is measured using a shift questionnaire assessed after indiviual work shifts. Rated on a 0-10 scale : * percieved family presence during the shift * amount of direct contact with the family members * perceived burden related to family presence * perceived support or positive contribution of family presence. Open-ended comments on factors influencing burden or support. Time points: T1 = implementation time point, during the early implementation period of the extended visiting policy (less then six months).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers6

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
17384930BACKGROUNDPubMed
31668437BACKGROUNDPubMed
39435240BACKGROUNDPubMed
41295830BACKGROUNDPubMed
42007199BACKGROUNDPubMed
42132067BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07887009

GET https://conductscience.org/api/trials/v1/NCT07887009/registered